Teresa Deluca

Teresa Maria Deluca currently works at Surgery Partners, Inc., as Independent Director from 2016, Lifestance Health Group, Inc., as Director from 2024, and Centenara Labs AG, as Director from 2022.
Dr. Deluca also formerly worked at Women Corporate Directors, as Co-Chairman & Member-Leadership Council, Walgreen Co., as VP-Clinical Sales & Director-National Medical from 2010 to 2011, PRA Health Sciences, Inc., as Senior Director-Product Development Service, The Trustees of Columbia University in The City of New York, as Managing Director-NY Life Science Venture Fund from 2018 to 2019, VISIONS, as Director, PRA International LLC, as Senior Director-Product Development Services, North Bud Farms, Inc., as Director from 2018 to 2020, 180 Life Sciences Corp., as Independent Director from 2021 to 2023, Humana, Inc., as Senior Vice President-Pharmacy Health Solutions in 2012, Thomas Jefferson University, as Chief Psychiatric Resident, GSK Plc, as Senior Medical Scientist, Icahn School of Medicine at Mount Sinai, as Assistant Clinical Professor from 2014 to 2017, Magellan Pharmacy Solutions, Inc., as Chief Medical Officer from 2012 to 2014, and Medco Group, Inc., as VP-Personalized Medicine & Clinical Quality from 2006 to 2009.
Dr. Deluca received her Masters Business Admin degree from Drexel University and doctorate degree from Thomas Jefferson University.